Systematic review of the bridgepoint system for crossing coronary and peripheral chronic total occlusions

Jedrek Wosik, Deborah Shorrock, Georgios Christopoulos, Anna Kotsia, Bavana V. Rangan, Michele Roesle, Spyros Maragkoydakis, Shuaib M. Abdullah, Subhash Banerjee, Emmanouil S. Brilakis

Research output: Contribution to journalArticle

14 Citations (Scopus)

Abstract

BACKGROUND: The BridgePoint system consists of the CrossBoss coronary catheter and Stingray CTO system (Boston Scientific) for coronary chronic total occlusions (CTOs), and the Viance crossing catheter and Enteer re-entry system (Covidien) for peripheral CTOs. METHODS: We performed a systematic review of the literature on the BridgePoint system published between October 2008 and August 2014, in accordance with the standards set forth in the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) statement. RESULTS: We identified a total of 20 studies: 12 studies on coronary CTOs (10 retrospective with 2 prospective case series) and 8 studies on peripheral CTOs (all retrospective). Among 320 patients undergoing coronary CTO intervention, pooled technical success and major adverse cardiac event rates were 77.1% and 3.8%, respectively. Among 175 patients undergoing peripheral CTO intervention, pooled technical success and major adverse events were 82.2% and 4.6%, respectively. Only 1 study reported long-term outcomes after use of the coronary BridgePoint system, demonstrating similar incidence of major adverse cardiac events between BridgePoint-treated and non-BridgePoint treated patients; however, the study had low power. CONCLUSIONS: The BridgePoint system is associated with high procedural success rates and low complication rates when used for crossing both coronary and peripheral CTOs.

Original languageEnglish (US)
Pages (from-to)269-276
Number of pages8
JournalJournal of Invasive Cardiology
Volume27
Issue number6
StatePublished - Jun 1 2015

Fingerprint

Catheters
Meta-Analysis
Incidence

Keywords

  • cardiac catheterization
  • chronic total occlusion
  • percutaneous coronary intervention
  • percutaneous peripheral CTO intervention

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine
  • Radiology Nuclear Medicine and imaging

Cite this

Systematic review of the bridgepoint system for crossing coronary and peripheral chronic total occlusions. / Wosik, Jedrek; Shorrock, Deborah; Christopoulos, Georgios; Kotsia, Anna; Rangan, Bavana V.; Roesle, Michele; Maragkoydakis, Spyros; Abdullah, Shuaib M.; Banerjee, Subhash; Brilakis, Emmanouil S.

In: Journal of Invasive Cardiology, Vol. 27, No. 6, 01.06.2015, p. 269-276.

Research output: Contribution to journalArticle

Wosik, Jedrek ; Shorrock, Deborah ; Christopoulos, Georgios ; Kotsia, Anna ; Rangan, Bavana V. ; Roesle, Michele ; Maragkoydakis, Spyros ; Abdullah, Shuaib M. ; Banerjee, Subhash ; Brilakis, Emmanouil S. / Systematic review of the bridgepoint system for crossing coronary and peripheral chronic total occlusions. In: Journal of Invasive Cardiology. 2015 ; Vol. 27, No. 6. pp. 269-276.
@article{98c807f93cbf40039758a51b78867aa4,
title = "Systematic review of the bridgepoint system for crossing coronary and peripheral chronic total occlusions",
abstract = "BACKGROUND: The BridgePoint system consists of the CrossBoss coronary catheter and Stingray CTO system (Boston Scientific) for coronary chronic total occlusions (CTOs), and the Viance crossing catheter and Enteer re-entry system (Covidien) for peripheral CTOs. METHODS: We performed a systematic review of the literature on the BridgePoint system published between October 2008 and August 2014, in accordance with the standards set forth in the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) statement. RESULTS: We identified a total of 20 studies: 12 studies on coronary CTOs (10 retrospective with 2 prospective case series) and 8 studies on peripheral CTOs (all retrospective). Among 320 patients undergoing coronary CTO intervention, pooled technical success and major adverse cardiac event rates were 77.1{\%} and 3.8{\%}, respectively. Among 175 patients undergoing peripheral CTO intervention, pooled technical success and major adverse events were 82.2{\%} and 4.6{\%}, respectively. Only 1 study reported long-term outcomes after use of the coronary BridgePoint system, demonstrating similar incidence of major adverse cardiac events between BridgePoint-treated and non-BridgePoint treated patients; however, the study had low power. CONCLUSIONS: The BridgePoint system is associated with high procedural success rates and low complication rates when used for crossing both coronary and peripheral CTOs.",
keywords = "cardiac catheterization, chronic total occlusion, percutaneous coronary intervention, percutaneous peripheral CTO intervention",
author = "Jedrek Wosik and Deborah Shorrock and Georgios Christopoulos and Anna Kotsia and Rangan, {Bavana V.} and Michele Roesle and Spyros Maragkoydakis and Abdullah, {Shuaib M.} and Subhash Banerjee and Brilakis, {Emmanouil S.}",
year = "2015",
month = "6",
day = "1",
language = "English (US)",
volume = "27",
pages = "269--276",
journal = "Journal of Invasive Cardiology",
issn = "1042-3931",
publisher = "HMP Communications",
number = "6",

}

TY - JOUR

T1 - Systematic review of the bridgepoint system for crossing coronary and peripheral chronic total occlusions

AU - Wosik, Jedrek

AU - Shorrock, Deborah

AU - Christopoulos, Georgios

AU - Kotsia, Anna

AU - Rangan, Bavana V.

AU - Roesle, Michele

AU - Maragkoydakis, Spyros

AU - Abdullah, Shuaib M.

AU - Banerjee, Subhash

AU - Brilakis, Emmanouil S.

PY - 2015/6/1

Y1 - 2015/6/1

N2 - BACKGROUND: The BridgePoint system consists of the CrossBoss coronary catheter and Stingray CTO system (Boston Scientific) for coronary chronic total occlusions (CTOs), and the Viance crossing catheter and Enteer re-entry system (Covidien) for peripheral CTOs. METHODS: We performed a systematic review of the literature on the BridgePoint system published between October 2008 and August 2014, in accordance with the standards set forth in the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) statement. RESULTS: We identified a total of 20 studies: 12 studies on coronary CTOs (10 retrospective with 2 prospective case series) and 8 studies on peripheral CTOs (all retrospective). Among 320 patients undergoing coronary CTO intervention, pooled technical success and major adverse cardiac event rates were 77.1% and 3.8%, respectively. Among 175 patients undergoing peripheral CTO intervention, pooled technical success and major adverse events were 82.2% and 4.6%, respectively. Only 1 study reported long-term outcomes after use of the coronary BridgePoint system, demonstrating similar incidence of major adverse cardiac events between BridgePoint-treated and non-BridgePoint treated patients; however, the study had low power. CONCLUSIONS: The BridgePoint system is associated with high procedural success rates and low complication rates when used for crossing both coronary and peripheral CTOs.

AB - BACKGROUND: The BridgePoint system consists of the CrossBoss coronary catheter and Stingray CTO system (Boston Scientific) for coronary chronic total occlusions (CTOs), and the Viance crossing catheter and Enteer re-entry system (Covidien) for peripheral CTOs. METHODS: We performed a systematic review of the literature on the BridgePoint system published between October 2008 and August 2014, in accordance with the standards set forth in the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) statement. RESULTS: We identified a total of 20 studies: 12 studies on coronary CTOs (10 retrospective with 2 prospective case series) and 8 studies on peripheral CTOs (all retrospective). Among 320 patients undergoing coronary CTO intervention, pooled technical success and major adverse cardiac event rates were 77.1% and 3.8%, respectively. Among 175 patients undergoing peripheral CTO intervention, pooled technical success and major adverse events were 82.2% and 4.6%, respectively. Only 1 study reported long-term outcomes after use of the coronary BridgePoint system, demonstrating similar incidence of major adverse cardiac events between BridgePoint-treated and non-BridgePoint treated patients; however, the study had low power. CONCLUSIONS: The BridgePoint system is associated with high procedural success rates and low complication rates when used for crossing both coronary and peripheral CTOs.

KW - cardiac catheterization

KW - chronic total occlusion

KW - percutaneous coronary intervention

KW - percutaneous peripheral CTO intervention

UR - http://www.scopus.com/inward/record.url?scp=84930454136&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84930454136&partnerID=8YFLogxK

M3 - Article

VL - 27

SP - 269

EP - 276

JO - Journal of Invasive Cardiology

JF - Journal of Invasive Cardiology

SN - 1042-3931

IS - 6

ER -